Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines

References

• Avakian AP, Singbeil B, Poston R et al. Safety and efficacy of fowl and pigeon pox vaccines administered in ovo to SPF and broiler chickens. Proceedings of the 48th West Poultry Disease Conference. Vancouver, Canada, 24–27 April 1999.
   Google Scholar
• Gagic M, St Hill CA, Sharma JM. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents. Avian Dis.43, 293–301 (1999).
   PubMed Web of Science ®Google Scholar
• Sharma JM, Zhang Y, Jensen D, Rautenschlein S, Yeh HY. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek’s disease, infectious bursal disease, Newcastle disease, and fowl pox. Avian Dis.46, 613–622 (2002).
   PubMed Web of Science ®Google Scholar
• Stone H, Mitchell B, Brugh M. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines. Avian Dis.41, 856–863 (1997).
   PubMed Web of Science ®Google Scholar
• Ebrahimi MM, Moghaddampour M, Tavassoli A, Shahsavandi S. Vaccination of chicks with experimental Newcastle disease and avian influenza oil-emulsion vaccines by in ovo inoculation. Arch. Razi Inst.51, 15–25 (2000).
   Google Scholar
• Mast J, Goddeeris BM. Development of immunocompetence of broiler chickens. Vet. Immunol. Immunopathol.70, 245–256 (1999).
   PubMed Web of Science ®Google Scholar
• Bar-Shira E, Friedman A. Development and adaptations of innate immunity in the gastrointestinal tract of the newly hatched chick. Dev. Comp. Immunol.30, 930–941 (2006).
   PubMed Web of Science ®Google Scholar
• Sharma JM, Graham CK. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek’s disease vaccine. Avian Dis.26, 860–870 (1982).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sharma JM. Early posthatch protection against Marek’s disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine. Avian Dis.45, 639–645 (2001).
   PubMed Web of Science ®Google Scholar
• Worthington KJ, Sargent BA, Davelaar FG, Jones RC. Immunity to avian pneumovirus infection in turkeys following in ovo vaccination with an attenuated vaccine. Vaccine21, 1355–1362 (2003).
   PubMed Web of Science ®Google Scholar
• Hess M, Huggins MB, Heincz U. Hatchability, serology and virus excretion following in ovo vaccination of chickens with an avian metapneumovirus vaccine. Avian Pathol.33, 576–580 (2004).
   PubMed Web of Science ®Google Scholar
• Wakenell PS, Sharma JM. Chicken embryonal vaccination with avian infectious bronchitis virus. Am. J. Vet. Res.47, 933–938 (1986).
   PubMed Web of Science ®Google Scholar
• Doelling VW, Poston RM, Martin A, Charniga LM, Griffin LK, Avakian AP. Non-interference of Inovocox, a live coccidial oocyst vaccine, with Marek’s disease vaccine or Bursaplex, a live bursal disease vaccine, after in ovo administration. Proceedings of the IXth International Coccidiosis Conference. Foz de Iguassu, Parana, Brazil, 19–23 September 2005.
   Google Scholar
• Avakian AP, Wakenell PS, Grosse D, Whitfill CE, Link D. Protective immunity to infectious bronchitis in broilers vaccinated against Marek’s disease either in ovo or at hatch and against infectious bronchitis at hatch. Avian Dis.44, 536–544 (2000).
   PubMed Web of Science ®Google Scholar
• Kelemen M, Forgach K, Ivan J et al. Pathological and immunological study of an in ovo complex vaccine against infectious bursal disease. Acta Vet. Hung.48, 443–454 (2000).
   PubMed Web of Science ®Google Scholar
• Sharma JM. The structure and function of the avian immune system. Acta Vet. Hung.45, 229–238 (1997).
   PubMed Web of Science ®Google Scholar
• Dunon D, Courtois D, Vainio O et al. Ontogeny of the immune system: γ/δ and α/β T cells migrate from thymus to the periphery in alternating waves. J. Exp. Med.186, 977–988 (1997).
   PubMed Web of Science ®Google Scholar
• Houssaint E, Belo M, Le Douarin NM. Investigations on cell lineage and tissue interactions in the developing bursa of Fabricius through interspecific chimeras. Dev. Biol.53, 250–264 (1976).
   PubMed Web of Science ®Google Scholar
• Pike KA, Baig E, Ratcliffe MJ. The avian B-cell receptor complex: distinct roles of Igα and Igβ in B-cell development. Immunol. Rev.197, 10–25 (2004).
   PubMed Web of Science ®Google Scholar
• John JL. The avian spleen: a neglected organ. Q. Rev. Biol.69, 327–351 (1994).
   PubMed Web of Science ®Google Scholar
• Jeurissen SH, Boonstra-Blom AG, Al-Garib SO, Hartog L, Koch G. Defence mechanisms against viral infection in poultry: a review. Vet. Q.22, 204–208 (2000).
   PubMed Web of Science ®Google Scholar
• Mast J, Goddeeris BM, Peeters K, Vandesande F, Berghman LR. Characterisation of chicken monocytes, macrophages and interdigitating cells by the monoclonal antibody KUL01. Vet. Immunol. Immunopathol.61, 343–357 (1998).
   PubMed Web of Science ®Google Scholar
• Qureshi MA, Heggen CL, Hussain I. Avian macrophage: effector functions in health and disease. Dev. Comp. Immunol.24, 103–119 (2000).
   PubMed Web of Science ®Google Scholar
• MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol.15, 323–350 (1997).
   PubMed Web of Science ®Google Scholar
• Sharma JM. Natural killer cell activity in chickens exposed to Marek’s disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens. Avian Dis.25, 882–893 (1981).
   PubMed Web of Science ®Google Scholar
• Garcia-Camacho L, Schat KA, Brooks RJ, Bounous DI. Early cell-mediated immune responses to Marek’s disease virus in two chicken lines with defined major histocompatibility complex antigens. Vet. Immunol. Immunopathol.95, 145–153 (2003).
   PubMed Web of Science ®Google Scholar
• Gobel TW, Chen CH, Cooper MD. Avian natural killer cells. Curr. Top. Microbiol. Immunol.212, 107–117 (1996).
   PubMed Web of Science ®Google Scholar
• Ricks CA, Avakian A, Bryan T et al. In ovo vaccination technology. Adv. Vet. Med.41, 495–515 (1999).
   PubMedGoogle Scholar
• Ahmad J, Sharma JM. Protection against hemorrhagic enteritis and Newcastle disease in turkeys by embryo vaccination with monovalent and bivalent vaccines. Avian Dis.37, 485–491 (1993).
   PubMed Web of Science ®Google Scholar
• Ahmad J, Sharma JM. Evaluation of a modified-live virus vaccine administered in ovo to protect chickens against Newcastle disease. Am. J. Vet. Res.53, 1999–2004 (1992).
   PubMed Web of Science ®Google Scholar
• Reddy SK, Sharma JM, Ahmad J et al. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek’s diseases in specific-pathogen-free chickens. Vaccine14, 469–477 (1996).
   PubMed Web of Science ®Google Scholar
• Karaca K, Sharma JM, Winslow BJ et al. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine16, 1496–1503 (1998).
   PubMed Web of Science ®Google Scholar
• Mebatsion T, Verstegen S, De Vaan LT, Romer-Oberdorfer A, Schrier CC. A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J. Virol.75, 420–428 (2001).
   PubMed Web of Science ®Google Scholar
• Wakenell PS, Sharma JM, Slocombe RF. Embryo vaccination of chickens with infectious bronchitis virus: histologic and ultrastructural lesion response and immunologic response to vaccination. Avian Dis.39, 752–765 (1995).
   PubMed Web of Science ®Google Scholar
• Martin A, Doelling VW, Charniga LM, Mathis GF, Heggen-Peay C, Poston RM. Growout performance following vaccination with Inovocox as compared to salinomycin. Proceedings of the IXth International Coccidiosis Conference. Foz de Iguassu, Parana, Brazil, 19–23 September 2005.
   Google Scholar
• Toro H, Tang DC, Suarez DL, Sylte MJ, Pfeiffer J, Van Kampen KR. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine25, 2886–2891 (2007).
   PubMed Web of Science ®Google Scholar
• Schultz-Cherry S, Dybing JK, Davis NL et al. Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses. Virology278, 55–59 (2000).
   PubMed Web of Science ®Google Scholar
• Ge J, Deng G, Wen Z et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J. Virol.81, 150–158 (2007).
   PubMed Web of Science ®Google Scholar
• Park MS, Steel J, Garcia-Sastre A, Swayne D, Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc. Natl Acad. Sci. USA103, 8203–8208 (2006).
   PubMed Web of Science ®Google Scholar
• Veits J, Wiesner D, Fuchs W et al. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc. Natl Acad. Sci. USA103, 8197–8202 (2006).
   PubMed Web of Science ®Google Scholar
• Tarpey I, Orbell SJ, Britton P et al. Safety and efficacy of an infectious bronchitis virus used for chicken embryo vaccination. Vaccine24, 6830–6838 (2006).
   PubMed Web of Science ®Google Scholar
• Kapczynski DR, Hilt DA, Shapiro D, Sellers HS, Jackwood MW. Protection of chickens from infectious bronchitis by in ovo and intramuscular vaccination with a DNA vaccine expressing the S1 glycoprotein. Avian Dis.47, 272–285 (2003).
   PubMed Web of Science ®Google Scholar
• Haygreen EA, Kaiser P, Burgess SC, Davison TF. In ovo DNA immunisation followed by a recombinant fowlpox boost is fully protective to challenge with virulent IBDV. Vaccine24, 4951–4961 (2006).
   PubMed Web of Science ®Google Scholar
• Haygreen L, Davison F, Kaiser P. DNA vaccines for poultry: the jump from theory to practice. Expert Rev. Vaccines4(1), 51–62 (2005).
   PubMed Web of Science ®Google Scholar
• Wakenell PS, Bryan T, Schaeffer J, Avakian A, Williams C, Whitfill C. Effect of in ovo vaccine delivery route on herpesvirus of turkeys/SB-1 efficacy and viremia. Avian Dis.46, 274–280 (2002).
   PubMed Web of Science ®Google Scholar
• Sharma JM, Lee LF, Wakenell PS. Comparative viral, immunologic, and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch. Am. J. Vet. Res.45, 1619–1623 (1984).
   PubMed Web of Science ®Google Scholar
• Jochemsen P, Jeurissen SH. The localization and uptake of in ovo injected soluble and particulate substances in the chicken. Poult. Sci.81, 1811–1817 (2002).
   PubMed Web of Science ®Google Scholar
• Fyfe L, Staines K, Smith A, Powers C, Beal R, Butter C. Development of bronchial-associated lymphoid tissue in the avian lung. Proceedings of the 9th Avian Immunology Research Group Meeting. Paris, France, 21–24 October 2006.
   Google Scholar
• Jeurissen SH, Janse EM, Koch G, De Boer GF. Postnatal development of mucosa-associated lymphoid tissues in chickens. Cell Tissue Res.258, 119–124 (1989).
   PubMed Web of Science ®Google Scholar
• Reese S, Dalamani G, Kaspers B. The avian lung-associated immune system: a review. Vet. Res.37, 311–324 (2006).
   PubMed Web of Science ®Google Scholar
• Bar-Shira E, Sklan D, Friedman A. Establishment of immune competence in the avian GALT during the immediate post-hatch period. Dev. Comp. Immunol.27, 147–157 (2003).
   PubMed Web of Science ®Google Scholar
• Negash T, al-Garib S, Gruys E. Comparison of in ovo and post-hatch vaccination with particular reference to infectious bursal disease. A review. Vet. Q.26, 76–87 (2004).
   PubMed Web of Science ®Google Scholar
• Kowalczyk K, Daiss J, Halpern J, Roth TF. Quantitation of maternal-fetal IgG transport in the chicken. Immunology54, 755–762 (1985).
   PubMed Web of Science ®Google Scholar
• Mast J, Gilson D, Morales D, Meulemans G, van den Berg TP. Transfer of material antibodies from the yolk sac to the chicken. In: Immunosuppressive Viral Diseases in Poultry, Annual Report and Proceedings 2001. van den Berg TP (Ed.). Office for Official Publications of the European Communities, Luxembourg 180–183 (2003).
   Google Scholar
• Tang DC, Johnston SA, Carbone DP. Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors. Cancer Gene Ther.1, 15–20 (1994).
   PubMed Web of Science ®Google Scholar
• Tang DC, Jennelle RS, Shi Z et al. Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cells. Hum. Gene Ther.8, 2117–2124 (1997).
   PubMed Web of Science ®Google Scholar
• He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl Acad. Sci. USA95, 2509–2514 (1998).
   PubMed Web of Science ®Google Scholar
• Zeng M, Smith SK, Siegel F et al. AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination. Biotechniques31, 260–262 (2001).
   PubMed Web of Science ®Google Scholar
• Lewis JA, Brown EL, Duncan PA. Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines. Dev. Biol. (Basel)123, 165–176 (2006).
   PubMedGoogle Scholar
• Perkins S. Selection and optimization of anion exchange resins for purification of type 5 adenovirus. Presented at Viral Vectors & Vaccines Conference. Southampton, Bermuda, 6–8 November 2006.
   Google Scholar
• Xiang ZQ, Yang Y, Wilson JM, Ertl HC. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology219, 220–227 (1996).
   PubMed Web of Science ®Google Scholar
• Shi Z, Zeng M, Yang G et al. Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines. J. Virol.75, 11474–11482 (2001).
   PubMed Web of Science ®Google Scholar
• Vos A, Neubert A, Pommerening E et al. Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. J. Gen. Virol.82, 2191–2197 (2001).
   PubMed Web of Science ®Google Scholar
• Gogev S, Vanderheijden N, Lemaire M et al. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine20, 1451–1465 (2002).
   PubMed Web of Science ®Google Scholar
• Sullivan NJ, Geisbert TW, Geisbert JB et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature424, 681–684 (2003).
   PubMed Web of Science ®Google Scholar
• Van Kampen KR, Shi Z, Gao P et al. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine23, 1029–1036 (2005).
   PubMed Web of Science ®Google Scholar
• Gao W, Soloff AC, Lu X et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol.80, 1959–1964 (2006).
   PubMed Web of Science ®Google Scholar
• Chiocca S, Kurzbauer R, Schaffner G, Baker A, Mautner V, Cotten M. The complete DNA sequence and genomic organization of the avian adenovirus CELO. J. Virol.70, 2939–2949 (1996).
   PubMed Web of Science ®Google Scholar
• Tan PK, Michou AI, Bergelson JM, Cotten M. Defining CAR as a cellular receptor for the avian adenovirus CELO using a genetic analysis of the two viral fibre proteins. J. Gen. Virol.82, 1465–1472 (2001).
   PubMed Web of Science ®Google Scholar
• Molinier-Frenkel V, Lengagne R, Gaden F et al. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J. Virol.76, 127–135 (2002).
   PubMed Web of Science ®Google Scholar
• Ehrhardt A, Xu H, Kay MA. Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo.J. Virol.77, 7689–7695 (2003).
   PubMed Web of Science ®Google Scholar
• Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol.36, 59–74 (1977).
   PubMed Web of Science ®Google Scholar
• Fallaux FJ, Bout A, van der Velde I et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther.9, 1909–1917 (1998).
   PubMed Web of Science ®Google Scholar
• Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol. Biotechnol.3, 207–220 (1995).
   PubMed Web of Science ®Google Scholar
• Zhu J, Grace M, Casale J et al. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum. Gene Ther.10, 113–121 (1999).
   PubMed Web of Science ®Google Scholar
• Maranga L, Aunins JG, Zhou W. Characterization of changes in PER.C6 cellular metabolism during growth and propagation of a replication-deficient adenovirus vector. Biotechnol. Bioeng.90, 645–655 (2005).
   PubMed Web of Science ®Google Scholar
• Evans RK, Nawrocki DK, Isopi LA et al. Development of stable liquid formulations for adenovirus-based vaccines. J. Pharm. Sci.93, 2458–2475 (2004).
   PubMed Web of Science ®Google Scholar
• Swayne DE, Beck JR, Kinney N. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis.44, 132–137 (2000).
   PubMed Web of Science ®Google Scholar
• Fumihito A, Miyake T, Sumi S, Takada M, Ohno S, Kondo N. One subspecies of the red junglefowl (Gallus gallus gallus) suffices as the matriarchic ancestor of all domestic breeds. Proc. Natl Acad. Sci. USA91, 12505–12509 (1994).
   PubMed Web of Science ®Google Scholar
• Marcus PI, Sekellick MJ. Interferon induction by viruses. XXV. Adenoviruses as inducers of interferon in developmentally aged primary chicken embryo cells. Acta Microbiol. Immunol. Hung.52, 291–308 (2005).
   PubMedGoogle Scholar